Improved Pharmacodynamic Potential of Rosuvastatin by Self-Nanoemulsifying Drug Delivery System: An in vitro and in vivo Evaluation

Código QR

Improved Pharmacodynamic Potential of Rosuvastatin by Self-Nanoemulsifying Drug Delivery System: An in vitro and in vivo Evaluation

Ravinder Verma,1 Ajeet Kaushik,2 Rafa Almeer,3 Md Habibur Rahman,4 Mohamed M Abdel-Daim,3,5 Deepak Kaushik1 1Department of Pharmaceutical Sciences, M.D. University, Rohtak, Haryana, 124001, India; 2NanoBioTech Laboratory, Health Systems Engineering, Department of Natural Sciences, Division of Scienc...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Verma R, Kaushik A, Almeer R, Rahman MH, Abdel-Daim MM, Kaushik D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	snedds rosuvastatin in vitro lipolysis nanotechnology d-optimal mixture design pharmacodynamic study Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/f9d0829078de497188e33f60571637bc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Comparisons of in vitro Fick’s first law, lipolysis, and in vivo rat models for oral absorption on BCS II drugs in SNEDDS
por: Ye J, et al.
Publicado: (2019)

In Vitro Evaluation of a Solid Supersaturated Self Nanoemulsifying Drug Delivery System (Super-SNEDDS) of Aprepitant for Enhanced Solubility
por: Hakan Nazlı, et al.
Publicado: (2021)

The Potential Synergistic Activity of Zolmitriptan Combined in New Self-Nanoemulsifying Drug Delivery Systems: ATR-FTIR Real-Time Fast Dissolution Monitoring and Pharmacodynamic Assessment
por: Abd El-Halim SM, et al.
Publicado: (2021)

LC DETERMINATION OF ROSUVASTATIN AND EZETIMIBE IN HUMAN PLASMA
por: ASHFAQ,MUHAMMAD, et al.
Publicado: (2013)

Defining the process parameters affecting the fabrication of rosuvastatin calcium nanoparticles by planetary ball mill
por: Alshora D, et al.
Publicado: (2019)

Wound Healing Activity of Opuntia ficus-indica Fixed Oil Formulated in a Self-Nanoemulsifying Formulation
por: Koshak AE, et al.
Publicado: (2021)

ROSUVASTATIN AS A POSSIBLE TREATMENT FOR SUDDEN SENSORINEURAL HEARING LOSS
por: Nadeem Ul Haq, et al.
Publicado: (2019)

Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles – Formulation and Pharmacodynamic Assessment
por: Awadeen RH, et al.
Publicado: (2020)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
por: Parson H
Publicado: (2010)

Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer
por: Wei Y, et al.
Publicado: (2016)

Rosuvastatin Nanomicelles Target Neuroinflammation and Improve Neurological Deficit in a Mouse Model of Intracerebral Hemorrhage
por: Zi L, et al.
Publicado: (2021)

Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin
por: Wang Z, et al.
Publicado: (2013)

Response Surface Optimization of Ultra-Elastic Nanovesicles Loaded with Deflazacort Tailored for Transdermal Delivery: Accentuated Bioavailability and Anti-Inflammatory Efficacy
por: Ali AA, et al.
Publicado: (2021)

Self-nanoemulsifying ramipril tablets: a novel delivery system for the enhancement of drug dissolution and stability
por: Alhasani KF, et al.
Publicado: (2019)

The use of rosuvastatin and alpha lipoic acid in patients with unstable angina
por: E.H. Zaremba, et al.
Publicado: (2017)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
por: Sydney B Long, et al.
Publicado: (2010)

Serum Predose Metabolic Profiling for Prediction of Rosuvastatin Pharmacokinetic Parameters in Healthy Volunteers
por: Anne Michelli Reis Silveira, et al.
Publicado: (2021)

Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug
por: Moshin K, et al.
Publicado: (2016)

COMPARISON OF LIPID LOWERING EFFECTS OF ROSUVASTATIN AND ATORVASTATIN IN TYPE 2 DIABETIC PATIENTS WITH PRIMARY HYPERLIPIDEMIA
por: Safina Shabbir, et al.
Publicado: (2020)

Surface modification of endovascular stents with rosuvastatin and heparin-loaded biodegradable nanofibers by electrospinning
por: Janjic M, et al.
Publicado: (2017)

Application of statistical experimental methods to optimize medium for exopolymer production by newly isolated Halobacterium sp. SM5
por: Lungmann,Patcharee, et al.
Publicado: (2007)

Effects of formulation types on pharmacodynamics of warfarin in patients with cerebral infarction and dysphagia
por: Kim YJ, et al.
Publicado: (2019)

Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
por: Marina G. Bubnova, et al.
Publicado: (2021)

The co-treatment of rosuvastatin with dapagliflozin synergistically inhibited apoptosis via activating the PI3K/AKt/mTOR signaling pathway in myocardial ischemia/reperfusion injury rats
por: Gong Lei, et al.
Publicado: (2020)

A Comparison on Effects of High Dose Rosuvastatin versus High Dose Atorvastatin on Lipid Profile and CRP Level in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Study
por: Mahboubeh Darban, et al.
Publicado: (2021)

Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences
por: Hanne Haahr, et al.
Publicado: (2020)

Concept and utility of population pharmacokinetic and pharmacokinetic/pharmacodynamic models in drug development and clinical practice
por: Roganović Maša, et al.
Publicado: (2021)

Evaluation of the single-dose pharmacokinetics and pharmacodynamics of apixaban in healthy Japanese and Caucasian subjects
por: Frost C, et al.
Publicado: (2018)

Optimization of nanoemulsion containing gemcitabine and evaluation of its cytotoxicity towards human fetal lung fibroblast (MRC5) and human lung carcinoma (A549) cells
por: Wahgiman NA, et al.
Publicado: (2019)

Differences in lipogenesis and lipolysis in obese and non-obese adult human adipocytes
por: CIFUENTES,MARIANA, et al.
Publicado: (2008)

NanoUPLC-QTOF-MS/MS Determination of Major Rosuvastatin Degradation Products Generated by Gamma Radiation in Aqueous Solution
por: Lucija Dončević, et al.
Publicado: (2021)

Formulation and optimization of gastroretentive bilayer tablets of calcium carbonate using D-optimal mixture design
por: Moganti Manasa, et al.
Publicado: (2021)

Glibenclamide population pharmacokinetic/pharmacodynamic modeling in South African type 2 diabetic subjects
por: Rambiritch V, et al.
Publicado: (2016)

Reduction in C-Peptide Levels and Influence on Pharmacokinetics and Pharmacodynamics of Insulin Preparations: How to Conduct a High-Quality Euglycemic Clamp Study
por: Yi Tao, et al.
Publicado: (2021)

Engineering of Long-Term Stable Transparent Nanoemulsion Using High-Gravity Rotating Packed Bed for Oral Drug Delivery
por: Wu HR, et al.
Publicado: (2020)

Pharmacodynamics of vancomycin in elderly patients aged 75 years or older with methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia
por: Mizokami F, et al.
Publicado: (2013)

Development of a kojic monooleate-enriched oil-in-water nanoemulsion as a potential carrier for hyperpigmentation treatment
por: Syed Azhar SNA, et al.
Publicado: (2018)

Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form
por: Rameshwar Gholve, et al.
Publicado: (2021)

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8
por: Andreas Port, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Integration of Enrofloxacin Following Single Oral Administration of Different Doses in Brown Trout (<i>Salmo trutta</i>)
por: Kamil Uney, et al.
Publicado: (2021)